Brensocatib becomes first licensed treatment for non‑cystic fibrosis bronchiectasis

23rd February 2026 Uncategorised 0

MHRA authorises medicine for patients aged 12 and over with repeated flare‑ups

More: Brensocatib becomes first licensed treatment for non‑cystic fibrosis bronchiectasis
Source: News